← Back to Search

Diet Modification for Obesity (WYE Trial)

N/A
Recruiting
Led By Ellen A Schur, MD, MS
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days of diet intervention
Awards & highlights

Summary

This trial explores how nutrition affects the brain and how it could lead to obesity. It uses MRI to study the hypothalamus.

Who is the study for?
This trial is for overweight individuals aged 20-40 with a BMI of 25-29.9, willing to try a new diet for two weeks and undergo MRI scans. It's not suitable for those with major health issues, metal implants, extreme diets like veganism, or who are pregnant.
What is being tested?
The study tests how three different diet modifications affect brain inflammation related to obesity by using MRI scans of the hypothalamus over a period of 14 days.
What are the potential side effects?
Since this trial involves dietary changes rather than medication, side effects may include typical reactions to diet adjustment such as changes in energy levels, mood swings, or digestive discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days of diet intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days of diet intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hypothalamic Gliosis

Trial Design

3Treatment groups
Experimental Treatment
Group I: Assigned Diet #3Experimental Treatment1 Intervention
Group II: Assigned Diet #2Experimental Treatment1 Intervention
Group III: Assigned Diet #1Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,791 Previous Clinical Trials
1,905,464 Total Patients Enrolled
2 Trials studying Gliosis
214 Patients Enrolled for Gliosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,410 Previous Clinical Trials
4,324,849 Total Patients Enrolled
2 Trials studying Gliosis
214 Patients Enrolled for Gliosis
Ellen A Schur, MD, MSPrincipal InvestigatorUniversity of Washington
1 Previous Clinical Trials
102 Total Patients Enrolled
1 Trials studying Gliosis
102 Patients Enrolled for Gliosis

Media Library

Diet modification #1 Clinical Trial Eligibility Overview. Trial Name: NCT05626907 — N/A
Gliosis Research Study Groups: Assigned Diet #1, Assigned Diet #3, Assigned Diet #2
Gliosis Clinical Trial 2023: Diet modification #1 Highlights & Side Effects. Trial Name: NCT05626907 — N/A
Diet modification #1 2023 Treatment Timeline for Medical Study. Trial Name: NCT05626907 — N/A
~10 spots leftby Mar 2025